INTERVIEW WITH NOEL CLARKE
Treating the Primary in High vs Low Volume Hormone Sensitive Disease

INTERVIEW WITH DECLAN MURPHY
Imaging Modalities to Treat Node-Positive Disease

INTERVIEW WITH FRED SAAD
The Risk of Dose De-intensifying Treatment, Bone Health in Prostate Cancer

INTERVIEW WITH COLIN PRITCHARD
Integrating Genomics and Genetics into Clinical Care for Prostate Cancer, A Pathologist's Perspective

Videos
State-of-the-industry video lectures by leading urology experts
Featured Videos

#ASCO14 - Poster: A randomized double-blind, comparative study of ARN-509 plus androgen deprivation therapy (ADT) vs ADT alone in non-metastatic castration-resistant prostate cancer–the SPARTAN trial

CHICAGO, IL USA (UroToday.com) - Presented by Matthew R. Smith,1 Glenn Liu,2 S. Martin Shreeve,3 Shannon Matheny,3 Antonieta Sosa,3 Thian Kheoh,3 Margaret K. Yu,3 and Eric J. Small4 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

asco 2014 ARN-509 smith TPS5100 thumb

1Harvard Medical School and Massachusetts General Hospital Cancer Center, Boston, MA USA
2University of Wisconsin Carbone Cancer Center, Madison, WI USA
3Janssen Research & Development, Los Angeles, CA USA
4University of California San Francisco, San Francisco, CA USA

 

 

 

Conference Coverage
 
Recent data from conferences worldwide
  • 2019 Annual Congress / October 17 - October 20 / Athens, Greece
  • 2019 Annual Meeting / October 3 - October 5 / Aarhus, Denmark
  • 2019 Annual Congress / September 27 - October 1 / Barcelona, Spain
  • 2019 Biennial Meeting / August 29-31 / Basel, Switzerland
  • 2019 Think Tank / August 8-10 / Washington, DC
  • 2019 Annual Meeting / May 31 - June 6 / Chicago, IL
  • 2019 Annual Meeting / May 3-6 / Chicago, IL
  • 2019 World Congress / May 1-3 / Liverpool, United Kingdom
  • 2019 Symposium / April 1-4 / Ottawa, ON
Journals
Publications focusing on urologic cancer treatments through original manuscripts
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe